Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5220536
Max Phase: Preclinical
Molecular Formula: C18H20N8O
Molecular Weight: 364.41
Associated Items:
ID: ALA5220536
Max Phase: Preclinical
Molecular Formula: C18H20N8O
Molecular Weight: 364.41
Associated Items:
Canonical SMILES: CC1(Cn2nc(-c3ccc4oc(N)nc4c3)c3c(N)nc(N)nc32)CCC1
Standard InChI: InChI=1S/C18H20N8O/c1-18(5-2-6-18)8-26-15-12(14(19)23-16(20)24-15)13(25-26)9-3-4-11-10(7-9)22-17(21)27-11/h3-4,7H,2,5-6,8H2,1H3,(H2,21,22)(H4,19,20,23,24)
Standard InChI Key: IRCGXDFJTQYSNR-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 364.41 | Molecular Weight (Monoisotopic): 364.1760 | AlogP: 2.57 | #Rotatable Bonds: 3 |
Polar Surface Area: 147.69 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 9 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 13.86 | CX Basic pKa: 5.78 | CX LogP: 2.32 | CX LogD: 2.31 |
Aromatic Rings: 4 | Heavy Atoms: 27 | QED Weighted: 0.50 | Np Likeness Score: -0.73 |
1. Oleksak P, Nepovimova E, Chrienova Z, Musilek K, Patocka J, Kuca K.. (2022) Contemporary mTOR inhibitor scaffolds to diseases breakdown: A patent review (2015-2021)., 238 [PMID:35688004] [10.1016/j.ejmech.2022.114498] |
Source(1):